Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Little Green Pharma Ltd. ( (AU:LGP) ) is now available.
Little Green Pharma Ltd has announced the quotation of 150,000 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of September 1, 2025. This move is part of the company’s strategic efforts to enhance its market presence and provide additional value to its stakeholders, potentially impacting its operational growth and industry positioning positively.
The most recent analyst rating on (AU:LGP) stock is a Buy with a A$0.18 price target. To see the full list of analyst forecasts on Little Green Pharma Ltd. stock, see the AU:LGP Stock Forecast page.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd operates in the pharmaceutical industry, focusing on the production and distribution of medical cannabis products. The company is known for its commitment to providing high-quality, plant-based medicines and has a market focus on both domestic and international markets.
Average Trading Volume: 153,872
Technical Sentiment Signal: Buy
Current Market Cap: A$37.34M
See more insights into LGP stock on TipRanks’ Stock Analysis page.